Charlebois ED - Search Results

1

Improved Viral Suppression With Streamlined Care in the SEARCH Study.

Hickey MD, Ayieko J, Kwarisiima D, Opel FJ, Owaraganise A, Balzer LB, Chamie G, Jain V, Peng J, Camlin C, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. Hickey MD, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):571-578. doi: 10.1097/QAI.0000000000002508. J Acquir Immune Defic Syndr. 2020. PMID: 32991337 Free PMC article.

2

Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.

Stanley HD, Charlebois E, Harb G, Jacobson MA. Stanley HD, et al. J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):272-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8106966

3

Continuous low-dose interferon-alpha therapy for HIV-related immune thrombocytopenic purpura.

Northfelt DW, Charlebois ED, Mirda MI, Child C, Kaplan LD, Abrams DI. Northfelt DW, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):45-50. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548345 Clinical Trial.

4

Provider assessment of adherence to HIV antiretroviral therapy.

Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Bangsberg DR, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):435-42. doi: 10.1097/00126334-200104150-00005. J Acquir Immune Defic Syndr. 2001. PMID: 11391162

5

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.

Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ. Staedke SG, et al. Among authors: charlebois ed. Lancet. 2001 Aug 4;358(9279):368-74. doi: 10.1016/S0140-6736(01)05557-X. Lancet. 2001. PMID: 11502317 Clinical Trial.

6

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Oyugi JH, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2. doi: 10.1097/00126334-200408150-00014. J Acquir Immune Defic Syndr. 2004. PMID: 15247564

7

Written clinic procedures enhance delivery of HIV "prevention with positives" counseling in primary health care settings.

Myers JJ, Steward WT, Charlebois E, Koester KA, Maiorana A, Morin SF. Myers JJ, et al. J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S95-S100. doi: 10.1097/01.qai.0000140607.36393.d3. J Acquir Immune Defic Syndr. 2004. PMID: 15385905

8

HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study.

Hahn JA, Bangsberg DR, McFarland W, Charlebois ED, Clark RA, Moss AR. Hahn JA, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1616-9. doi: 10.1097/00126334-200412150-00015. J Acquir Immune Defic Syndr. 2004. PMID: 15577419

9

Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics.

Srikantiah P, Charlebois E, Havlir DV. Srikantiah P, et al. J Infect Dis. 2005 Jan 15;191(2):147-9. doi: 10.1086/426832. Epub 2004 Dec 13. J Infect Dis. 2005. PMID: 15609222 No abstract available.

10

Potential deterrent effect of name-based HIV infection surveillance.

Charlebois ED, Maiorana A, McLaughlin M, Koester K, Gaffney S, Rutherford GW, Morin SF. Charlebois ED, et al. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):219-27. J Acquir Immune Defic Syndr. 2005. PMID: 15905740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page